Fundraising Fox

Iyuda Therapeutics

Owings Mills, US · Delaware corporation

Biotech

Founders & leadership

RT
Robert TennantChief Executive Officer
EF
Ephraim FuchsNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$4.5M disclosed across 5 rounds · 2023–2026

▶$600KraisedApr 2026 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert TennantExecutive Officer
  • Ephraim FuchsDirector
Offering amount
$600K
Amount sold
$600K
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedJun 2025 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert TennantExecutive Officer
  • Ephraim FuchsDirector
Offering amount
$1.3M
Amount sold
$1.3M
First sale
Oct 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$342.7KraisedSep 2023 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert TennantExecutive Officer
  • Ephraim FuchsDirector
Offering amount
$342.7K
Amount sold
$342.7K
Minimum investment
$12.4K
First sale
Aug 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$900KraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert TennantExecutive Officer
  • Ephraim FuchsDirector
Offering amount
$900K
Amount sold
$900K
Minimum investment
$900K
First sale
Aug 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.4MraisedSep 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ephraim FuchsDirector
  • Robert TennantExecutive Officer
Offering amount
$1.4M
Amount sold
$1.4M
Minimum investment
$1.4M
First sale
Sep 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Iyuda Therapeutics raised?
Iyuda Therapeutics has disclosed $4.5M raised across 5 rounds.
Where is Iyuda Therapeutics headquartered?
Iyuda Therapeutics is headquartered in Owings Mills, US.